எண்டோவாஸ்குலர் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எண்டோவாஸ்குலர் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எண்டோவாஸ்குலர் மருந்து Today - Breaking & Trending Today

Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome


Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome
Like a blocked water line, obstructions in blood vessels in the human circulatory system can cause serious problems. This is especially the case in superior vena cava syndrome (SVCS), in which oxygen-depleted blood returning from the head, upper chest, and arms is partially or completely prevented from reaching the heart. The result, however, is far more serious than the inconvenience of low water pressure from a clogged pipe - SVCS requires immediate attention.
Each year, some 15,000 people in the United States are affected by SVCS, symptoms of which include facial swelling, difficulty breathing, chest pain, mental confusion, and sometimes coma. A tumor compressing the superior vena cava vessel is the most common cause, but the condition can also result from intravascular devices, such as catheters and pacemakers, that may compress or obstruct the vessel. ....

United States , Riyaz Bashir , Stephanie Clare Roth , Emily Henderson , Endovascular Medicine At Temple University Hospital , Biomedical Research Services Librarian , Cochrane Library , Ginsburg Health Sciences Library At Temple University , Lewis Katz School , Temple University , Endovascular Medicine , Collaborator Stephanie Clare Roth , Research Services Librarian , Ginsburg Health Sciences Library , ஒன்றுபட்டது மாநிலங்களில் , ரியாஸ் பஷீர் , எமிலி ஹென்டர்சன் , எண்டோவாஸ்குலர் மருந்து இல் கோயில் பல்கலைக்கழகம் மருத்துவமனை , கோக்ரேன் நூலகம் , லெவிஸ் க்யாட்ஸ் பள்ளி , கோயில் பல்கலைக்கழகம் , எண்டோவாஸ்குலர் மருந்து , ஆராய்ச்சி சேவைகள் நூலகர் ,

Avinger, Inc.: New Publications Highlight Clinical Benefits of Avinger PAD Therapies


Avinger, Inc.: New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the publication of two clinical studies in peer-reviewed journals, further supporting the clinical benefits of its therapeutic devices. The studies were based on separate clinical case series conducted by physicians at the Division of Cardiovascular Disease and Endovascular Medicine at the Einstein Medical Center in Philadelphia, Pennsylvania.
These two studies demonstrate the utility of Avinger s OCT-guided approach for the treatment of PAD in complex and challenging cases and patient populations, commented Dr. Jon George, an interventional cardiologist and endovascular specialist at the University of Pennsylvani ....

Redwood City , United States , University Of Pennsylvania , Jaafer Golzar , Matt Kreps , Jon George , Mark Weinswig , Avinger Inc , Division Of Cardiovascular Disease , Exchange Commission On , Einstein Medical Center , University Of Pennsylvania Health System , Securities Exchange , Darrow Associates Investor Relations , Peripheral Artery Disease , Cardiovascular Disease , Endovascular Medicine , Pennsylvania Health System , Chief Medical Officer , Critical Limb Ischemia , Center Experience , Below The Knee Critical Limb Ischemia , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report ,